MOMENT-V, a telehealth-plus-mHealth intervention, is feasible for young adults with cannabis use disorder in primary care
This pilot randomized controlled trial protocol evaluates the feasibility of MOMENT-V, a fully remote brief intervention combining telehealth motivational enhancement therapy with mobile health ecological momentary intervention, versus enhanced usual care in 60 young adults with cannabis use disorder. Primary outcomes include intervention and trial feasibility measures (completion, engagement, acceptability, screening, eligibility, enrollment, retention) against a priori benchmarks. The study is ongoing, with recruitment from August 2025 to January 2027 and data collection projected to end in July 2027.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
MOMENT-V, a telehealth-plus-mHealth intervention, is feasible for young adults with cannabis use disorder in primary care The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
MOMENT-V, a telehealth-plus-mHealth intervention, is feasible for young adults with cannabis use disorder in primary care
This conclusion is most relevant to: Young adults aged 18-26 years with cannabis use disorder (CUD) recruited from primary care clinics.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Telehealth-Plus-mHealth Intervention for Young Adults With Cannabis Use Disorder: Protocol for a Pilot Randomized Controlled Trial. (JMIR research protocols, 2026) —
How It Works
The proposed biological pathway:
- ▸Telehealth motivational enhancement therapy sessions (2 weekly) address motivation and stigma barriers
- ▸Mobile health ecological momentary intervention provides self-monitoring and personalized messages after trigger reports
- ▸Fully remote delivery increases accessibility and reduces time/financial barriers
- ▸Result: Improved feasibility and engagement in treatment for young adults with CUD
Who Might Benefit
Evidence fit by population:
- ▸Young adults aged 18-26 years with cannabis use disorder (CUD) recruited from primary care clinics
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Pilot study with small sample size (N=60) limits generalizability
- ▸Feasibility outcomes are primary; efficacy outcomes are secondary and not powered for definitive conclusions
Frequently Asked Questions
What is MOMENT-V?▼
MOMENT-V is a digital health intervention combining telehealth motivational enhancement therapy with mobile health ecological momentary intervention for young adults with cannabis use disorder.
Who is eligible for this study?▼
Primary care patients aged 18-26 years with a Cannabis Use Disorder Identification Test-Revised score ≥12, cannabis use ≥3 days/week, and smartphone ownership.
What are the primary outcomes of this trial?▼
Primary outcomes are feasibility measures: intervention completion, EMI engagement, acceptability, and trial screening, eligibility, enrollment, and retention rates.
When will results be available?▼
Data collection is projected to be completed in July 2027, with a manuscript describing main outcomes planned for early 2028.
References
- 1.Shrier LA, Palmer A, Parker S, Kossowsky J, Katz-Wise SL, Burke PJ, Milliren CE, Harris SK. “Telehealth-Plus-mHealth Intervention for Young Adults With Cannabis Use Disorder: Protocol for a Pilot Randomized Controlled Trial..” JMIR research protocols, 2026. PMID: 42622852 DOI: 10.2196/105908